Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding

Acta Neurochirurgica

Volumn 152, Issue 2, 2010, Pages 257-262

  Ruigrok, Ynte M ^a   Slooter, Arjen J C ^b   Rinkel, Gabriel J E ^a   Wijmenga, Cisca ^b,c   Rosendaal, Frits R ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coagulation; Genes; Intracranial aneurysm; Subarachnoid hemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; BLOOD CLOTTING FACTOR 5 LEIDEN; METHYLENETETETRAHYDROFOLATE REDUCTASE; OXIDOREDUCTASE; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BLOOD CLOTTING; BRAIN ISCHEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAZARD RATIO; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BLOOD PROTEINS; BRAIN ISCHEMIA; COAGULATION PROTEIN DISORDERS; DNA MUTATIONAL ANALYSIS; FACTOR XIII; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECURRENCE; RISK FACTORS; SUBARACHNOID HEMORRHAGE;

EID: 77949275836     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-009-0505-0     Document Type: Article

References (30)

1. HP Adams Jr NF Kassell JC Torner EC Haley Jr 1987 Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influence of clinical condition, CT results and antifibrinolytic therapy: a report from the Cooperative Aneurysm Study Neurology 37 1586 1591 3658161
2. R Anwar L Gallivan SD Edmonds AF Markham 1999 Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity Blood 93 897 901 1:CAS:528:DyaK1MXpsFyisw%3D%3D 9920838
3. RA Ariens H Philippou C Nagaswami JW Weisel DA Lane PJ Grant 2000 The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood 96 988 995 1:CAS:528: DC%2BD3cXltlKitb8%3D 10910914
4. WM van den Bergh A Algra F van Kooten CM Dirven J van Gijn M Vermeulen GJ Rinkel MASH Study Group 2005 Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial Stroke 36 1011 1015 10.1161/01.STR.0000160801.96998.57 15790946 (Pubitemid 40629294)
5. RM Bertina BP Koeleman T Koster FR Rosendaal RJ Dirven H de Ronde PA van der Velden PH Reitsma 1994 Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 64 67 10.1038/369064a0 1:CAS:528:DyaK2cXktVKnt7c%3D 8164741 (Pubitemid 24144355)
6. EH Brilstra GJE Rinkel A Algra J van Gijn 2000 Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage Neurology 55 1656 1660 1:STN:280:DC%2BD3M%2FnvFSrtQ%3D%3D 11113219
7. BS Donahue D Gailani MS Higgins DC Drinkwater AL George Jr 2003 Factor V Leiden protects against blood loss and transfusion after cardiac surgery Circulation 107 1003 1008 10.1161/01.CIR.0000051864.28048.01 1:CAS:528:DC%2BD3sXjt1yjs74%3D 12600914 (Pubitemid 36258724)
8. CG Drake 1988 Report of World Federation on Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale J Neurosurg 68 985 986
9. P Frosst HJ Blom R Milos P Goyette CA Sheppard RG Matthews GJ Boers M den Heijer LA Kluijtmans LP van den Heuvel R Rozen 1995 A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 111 113 10.1038/ng0595-111 1:CAS:528:DyaK2MXlsVymt78%3D 7647779
10. Y Fujii S Takeuchi O Sasaki T Minakawa T Koike R Tanaka 1996 Ultra-early rebleeding in spontaneous subarachnoid hemorrhage J Neurosurg 84 35 42 10.3171/jns.1996.84.1.0035 1:STN:280:DyaK287htVyhsg%3D%3D 8613833
11. A Hijdra PJAM Brouwers M Vermeulen J van Gijn 1990 Grading the amount of blood on computed tomograms after subarachnoid hemorrhage Stroke 21 1156 1161 1:STN:280:DyaK3czlslehtg%3D%3D 2389295
12. A Hijdra J van Gijn N Nagelkerke M Vermeulen H van Crevel 1988 Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage Stroke 19 1250 1256 1:STN:280:DyaL1M%2FitVWruw%3D%3D 3176085
13. A Hijdra M Vermeulen J van Gijn H van Crevel 1987 Rerupture of intracranial aneurysms: a clinicoanatomic study J Neurosurg 67 29 33 10.3171/jns.1987.67.1.0029 1:STN:280:DyaL2s3ltlemsQ%3D%3D 3598669
14. J Hillman S Fridriksson O Nilsson Z Yu H Saveland KE Jakobsson 2002 Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study J Neurosurg 97 771 778 10.3171/jns.2002.97.4.0771 1:CAS:528: DC%2BD38XosFehtLs%3D 12405362
15. JW Hop GJE Rinkel A Algra J van Gijn 1997 Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review Stroke 28 660 664 1:STN:280:DyaK2s3gvFehug%3D%3D 9056628
16. S Kangsadalampai PG Board 1998 The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity Blood 92 2766 2770 1:CAS:528:DyaK1cXms1eltL8%3D 9763561
17. RJ Kim RC Becker 2003 Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies Am Heart J 146 948 957 10.1016/S0002-8703(03)00519-2 1:CAS:528:DC%2BD3sXps1OmsLs%3D 14660985 (Pubitemid 37500767)
18. N Komanasin AJ Catto TS Futers A van Hylckama Vlieg FR Rosendaal RA Ariens 2005 A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis J Thromb Haemost 3 2487 2496 10.1111/j.1538-7836.2005.01624.x 1:CAS:528:DC%2BD2MXht1KktLzI 16241947 (Pubitemid 41727166)
19. PG Lindqvist PJ Svensson K Marsaal L Grennert M Luterkort B Dahlback 1999 Activated protein C resistance (FV:Q506) and pregnancy Thromb Haemost 81 532 537 1:CAS:528:DyaK1MXisFSls7g%3D 10235434
20. FHH Linn GJE Rinkel A Algra J van Gijn 1996 Incidence of subarachnoid hemorrhage. Role of region, year, and rate of computed tomography: a meta-analysis Stroke 27 625 629 1:STN:280:DyaK287ot1equg%3D%3D 8614919
21. P Nina G Schisano F Chiappetta M Luisa Papa E Maddaloni A Brunori F Capasso MG Corpetti F Demurtas 2001 A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome Surg Neurol 55 197 203 10.1016/S0090-3019(01)00402-5 1:STN:280:DC%2BD3M3mvVWgsg%3D%3D 11358585 (Pubitemid 32453178)
22. SR Poort FR Rosendaal PH Reitsma RM Bertina 1996 A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 3698 3703 1:CAS:528:DyaK28XntVahsLg%3D 8916933
23. CH Rabb G Tang LS Chin SL Giannotta 1994 A statistical analysis of factors related to symptomatic cerebral vasospasm Acta Neurochir (Wien) 127 27 31 10.1007/BF01808542 1:STN:280:DyaK2M%2FivVKnuw%3D%3D
24. AP Reiner SM Schwartz MB Frank WT Longstreth Jr LA Hindorff G Teramura FR Rosendaal LK Gaur BM Psaty DS Siscovick 2001 Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women Stroke 32 2580 2586 10.1161/hs1101.098150 1:CAS:528:DC%2BD3MXptVGqsLg%3D 11692020
25. GJ Rinkel VL Feigin A Algra WM van den Bergh M Vermeulen J van Gijn 2005 Calcium antagonists for aneurysmal subarachnoid haemorrhage Cochrane Database Syst Rev 1 CD000277 15674871
26. GJ Rinkel J van Gijn EF Wijdicks 1993 Subarachnoid hemorrhage without detectable aneurysm. A review of the causes Stroke 24 1403 1409 1:STN:280:DyaK3szmvFyltg%3D%3D 8362440
27. YB Roos LF Beenen RJ Groen KW Albrecht M Vermeulen 1997 Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery J Neurol Neurosurg Psychiat 63 490 493 10.1136/jnnp.63.4.490 1:STN:280: DyaK1c%2FgtFaqtg%3D%3D 9343129
28. YB Roos GJ Rinkel M Vermeulen A Algra J van Gijn 2003 Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage Cochrane Database Syst Rev 2 CD001245 12804399
29. AJC Slooter FR Rosendaal BC Tanis J Kemmeren Y van der Graaf A Algra 2005 Prothrombotic conditions, oral contraceptives and the risk of ischemic stroke J Thromb Haemost 3 1213 1217 10.1111/j.1538-7836.2005.01442.x 1:CAS:528:DC%2BD2MXms1aru7Y%3D 15946211 (Pubitemid 41725244)
30. MD Vergouwen CJ Frijns YB Roos GJ Rinkel F Baas M Vermeulen 2004 Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage Stroke 35 1280 1283 10.1161/01.STR.0000128707.48644.7e 1:CAS:528:DC%2BD2cXktFyrsr8%3D 15105509 (Pubitemid 38697443)